Hochschulschrift
Determination of thrombin activatable fibrinolysis inhibitor (TAFI) activity by liquid chromatography/electrospray ionization mass spectrometry and its potential role in hemophilia : = Bestimmung der Thrombin-aktivierbarer Fibrinolyseinhibitor (TAFI)-Aktivität durch Flüssigkeitschromatographie/Tandem-Massenspektrometrie und die mögliche Rolle bei Hämophilie-Patienten
- Alternative title
-
Bestimmung der Thrombin-aktivierbarer Fibrinolyseinhibitor (TAFI)-Aktivität durch Flüssigkeitschromatographie/Tandem-Massenspektrometrie und die mögliche Rolle bei Hämophilie-Patienten
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
75 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen
Friedrich-Alexander-Universität Erlangen-Nürnberg, Dissertation, 2017
- Classification
-
Medizin, Gesundheit
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:33 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2017
Other Objects (12)
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Untersuchungen zur interindividuellen Variation der Konzentration von Thrombin Activatable Fibrinolysis Inhibitor (TAFI) und seiner Korrelation zu Parametern des Stoffwechsels und der Blutgerinnung
Cellular Thrombin Binding
Thrombin-Bindung durch Fibrin
Thrombin als potentieller Angiogenesefaktor
Thrombin-Generierung durch Asparaginase
Thrombin generation by gentamicin
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Untersuchungen zur interindividuellen Variation der Konzentration von Thrombin Activatable Fibrinolysis Inhibitor (TAFI) und seiner Korrelation zu Parametern des Stoffwechsels und der Blutgerinnung
Cellular Thrombin Binding
Thrombin-Bindung durch Fibrin
Thrombin als potentieller Angiogenesefaktor
Thrombin-Generierung durch Asparaginase
Thrombin generation by gentamicin
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
Untersuchungen zur interindividuellen Variation der Konzentration von Thrombin Activatable Fibrinolysis Inhibitor (TAFI) und seiner Korrelation zu Parametern des Stoffwechsels und der Blutgerinnung
Cellular Thrombin Binding
Thrombin-Bindung durch Fibrin
Thrombin als potentieller Angiogenesefaktor
Thrombin-Generierung durch Asparaginase